
NewsWPLG Local 10 – Main FeedAugust 20, 2026Miami-Dade County
World Health Organization allocates 70,000 doses of Ervebo vaccine to Congo for Ebola outbreak
Photo: WPLG Local 10 – Main Feed
The World Health Organization and partners are sending 70,000 doses of the Ervebo vaccine to Congo to address the current Ebola outbreak. While the vaccine is licensed for a different strain of the virus, it will be used for front-line health workers and a clinical trial to determine its effectiveness against the current Bundibugyo virus strain.
Read the full story at WPLG Local 10 – Main FeedWhy It Matters
This deployment represents a major international effort to contain the fastest-spreading Ebola outbreak in history, which has already resulted in 2,476 deaths.
Key Facts
- 70,000 total doses of Ervebo vaccine are being sent to Congo.
- 20,000 doses are designated for a Phase 3 clinical trial to test efficacy against the Bundibugyo virus.
- 50,000 doses are designated for front-line and health workers.
- The current outbreak has caused 2,476 deaths out of 5,208 confirmed cases.
- The overall case fatality rate is 47.5%, reaching up to 70% in North Kivu province.
- The outbreak is spreading three times faster than the 2014-2016 West Africa outbreak.
- The Ervebo vaccine is not currently licensed for the specific Bundibugyo virus strain causing this outbreak.
- The outbreak was officially declared on May 15, though experts believe it began as early as February.
- The virus is currently spreading in six provinces in eastern Congo.
Who's Mentioned
PersonTedros Adhanom Ghebreyesus“WHO Director-General.”locationMongbwalu“Mining town where the virus is believed to have originated.”OrganizationWorld Health Organization“Lead agency coordinating the vaccine distribution.”locationNorth Kivu“Province with a 70% fatality rate.”locationCongo“The country currently experiencing the Ebola outbreak.”
